We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Trade smarter, not harder: Unleash your inner pro with our toolkit and live discussions.
The current CLRB market cap is 10.05M. The company's latest EPS is USD and P/E is N/A.
| Quarter End | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Total Revenue | 0 | 0 | 0 | 0 | 0 |
| Operating Income | -9.41M | -12.55M | -12M | -13.7M | -13.33M |
| Net Income | -13.73M | -7.45M | -21.58M | -5.98M | -14.67M |
| Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Total Revenue | 0 | 0 | 0 | 0 | 0 |
| Operating Income | -14.18M | -15.29M | -24.13M | -28.81M | -38.96M |
| Net Income | -14.09M | -15.09M | -24.12M | -28.6M | -37.98M |
| Quarter End | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Total Assets | 21.55M | 12.08M | 42.91M | 29.39M | 37.29M |
| Total Liabilities | 16.98M | 13.43M | 16.74M | 15.62M | 20.75M |
| Total Equity | -13.35M | -1.36M | 26.17M | 12.38M | 15.17M |
| Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Total Assets | 12.25M | 58.66M | 37.2M | 21.59M | 12.08M |
| Total Liabilities | 3.19M | 3.86M | 4.16M | 6.08M | 13.43M |
| Total Equity | 9.06M | 54.8M | 33.05M | 15.51M | -1.36M |
| Quarter End | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Operating | -22.78M | -32.38M | -13.36M | -27.5M | -36.67M |
| Investing | -597k | -864k | -22k | -43k | -43k |
| Financing | 22.5M | 22.94M | 43.85M | 43.85M | 61.41M |
| Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Operating | -11.69M | -13.93M | -22.57M | -25.22M | -32.38M |
| Investing | -25k | -62k | -141k | -226k | -864k |
| Financing | 9.02M | 60.55M | 1.25M | 9.61M | 22.94M |
| Market Cap | 10.05M |
| Price to Earnings Ratio | N/A |
| Price to Sales Ratio | 0 |
| Price to Cash Ratio | 0 |
| Price to Book Ratio | 0 |
| Dividend Yield | - |
| Shares Outstanding | 41.27M |
| Average Volume (1 week) | 2.19M |
| Average Volume (1 Month) | 3.24M |
| 52 Week Change | -93.14% |
| 52 Week High | 4.45 |
| 52 Week Low | 0.224 |
| Spread (Intraday) | 0 (0.33%) |
| Company Name | Cellectar Biosciences Inc |
| Address |
1209 orange street wilmington, delaware 19801 |
| Website | https://www.cellectar.com |
| Industry | pharmaceutical preparations (2834) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: 1-888-992-3836 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
